Edwards Lifesciences Corporation (EW) Revenue 2016–2025
Edwards Lifesciences Corporation (EW) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$6.1BFY2025 · since FY2016: $3.0B → $6.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.1B | +11.5% |
| FY2024 | $5.4B | +8.6% |
| FY2023 | $5.0B | +12.2% |
| FY2022 | $4.5B | -14.7% |
| FY2021 | $5.2B | +19.3% |
| FY2020 | $4.4B | +0.9% |
| FY2019 | $4.3B | +16.8% |
| FY2018 | $3.7B | +8.4% |
| FY2017 | $3.4B | +15.9% |
| FY2016 | $3.0B | — |
Source: SEC XBRL filings · For reference only · Not investment advice